Physician profile
Cameron Rice
NPI 1881434538
$697.87
in general payments reported to CMS, 2019-2025
16 companies · $645 in 2025
The $645 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $53.15 · 2025: $645.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $698.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $697.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $179.55 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $74.04 | 2025 | Caplyta |
| Novo Nordisk INC | $67.64 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Corcept Therapeutics | $54.48 | 2025 | Korlym |
| Astrazeneca Pharmaceuticals LP | $51.46 | 2025 | Airsupra, Farxiga |
| Pfizer INC. | $44.49 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.23 | 2025 | Xifaxan |
| Amgen INC. | $28.98 | 2025 | Repatha, Otezla |
| Cycle Pharmaceuticals INC | $26.14 | 2024-2025 | Tascenso Odt |
| Acadia Pharmaceuticals INC | $23.76 | 2025 | Nuplazid |
| Inspire Medical Systems, INC. | $22.60 | 2025 | Inspire |
| Merck Sharp & Dohme LLC | $22.26 | 2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.78 | 2025 | Jardiance |
| Sumitomo Pharma America, INC. | $16.57 | 2025 | Gemtesa |
| Lilly USA, LLC | $15.26 | 2025 | Zepbound, Mounjaro |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acella Pharmaceuticals, LLC | $13.63 | 2025 | NP Thyroid 60 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.